Major Depressive Disorder - Current and Future Players

Albany, New York, Feb 02, 2017

"Major Depressive Disorder - Current and Future Players" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.

Description-

GlobalData has released its pharma report, Major Depressive Disorder - Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing MDD Market. The report identifies and analyses the key companies shaping and driving the global MDD market. The report provides insight into the competitive MDD landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalDatas team of industry experts.

Get Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=943636

* Scope

- Investigation of current and future market competition for MDD

- Competitor assessment

- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.

- Strategic assessment of MDD sector through market impact analysis, future market scenario and company analysis

* Reasons to buy

- Gain a high level view of the trends shaping and driving MDD market

- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.

- Create an effective counter-strategy to gain a competitive advantage against those currently in the market

- Whats the next big thing in the global MDD market landscape? Identify, understand and capitalize

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 6

2 Introduction 7

2.1 Related Reports 7

2.2 Upcoming Related Reports 8

3 Market Outlook 9

3.1 Global Markets 9

3.1.1 Forecast 9

3.1.2 Drivers and Barriers - Global Issues 16

4 Current and Future Players 17

4.1 Overview 17

4.2 Trends in Corporate Strategy 19

4.3 Company Profiles 20

4.3.1 Allergan 20

4.3.2 e-Therapeutics 23

4.3.3 Alkermes 25

4.3.4 Pfizer 27

4.3.5 Otsuka 29

4.3.6 Janssen 32

4.3.7 Eli Lilly 35

4.3.8 Lundbeck 37

4.3.9 Takeda 40

4.3.10 Axsome Therapeutics 42

5 Appendix 44

5.1 Bibliography 44

5.2 Abbreviations 90

5.3 Methodology 101

5.4 Forecasting Methodology 101

5.4.1 Diagnosed NSCLC Patients 101

5.4.2 Percent Drug-Treated Patients 102

5.4.3 Drugs Included in Each Therapeutic Class 102

5.4.4 Launch and Patent Expiry Dates 105

5.4.5 General Pricing Assumptions 107

5.4.6 Individual Drug Assumptions 109

5.4.7 Generic Erosion 123

5.4.8 Pricing of Pipeline Agents 123

5.5 Primary Research - KOLs 128

5.5.1 KOLs 128

5.6 About the Authors 132

5.6.1 Analyst 132

5.6.2 Therapy Area Director 132

5.6.3 Epidemiologist 133

5.6.4 Global Head of Healthcare 133

5.7 About GlobalData 135

5.8 Disclaimer 135